dengue viral replication inhibitors (Catholic University of Leuven/Johnson & Johnson)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedengue viral replication inhibitors (Catholic University of Leuven/Johnson & Johnson)
Drug Alias Namedengue viral replication inhibitors (Catholic University of Leuven/KU Leuven R&D)dengue virus inhibitors (KU Leuven R&D)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKu Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKu LeuvenJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsDengue

Other Information

ATC CodeN/A
Related LinksN/A